20 juin 2020 - NIH Stops HCQ Trials
Description:
"A data and safety monitoring board (DSMB) met...and determined that while there was no harm, the study drug was very unlikely to be beneficial to hospitalized patients with COVID-19. After its fourth interim analysis the DSMB, which regularly monitors the trial, recommended to the National Heart, Lung, and Blood Institute (NHLBI), part of NIH, to stop the study." [14]Ajouté au bande de temps:
Date:
20 juin 2020
Maintenaint
~ Il y a 5 ans